Max Donley

2016 - Sucampo Pharmaceuticals

In 2016, Max Donley earned a total compensation of $1.2M as EVP, Global Human Resources, Information Technology and Strategy at Sucampo Pharmaceuticals, a 40% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$268,753
Option Awards$546,713
Salary$390,876
Other$9,000
Total$1,215,342

Donley received $546.7K in option awards, accounting for 45% of the total pay in 2016.

Donley also received $268.8K in non-equity incentive plan, $390.9K in salary and $9K in other compensation.

Rankings

In 2016, Max Donley's compensation ranked 7,316th out of 14,075 executives tracked by ExecPay. In other words, Donley earned more than 48.0% of executives.

ClassificationRankingPercentile
All
7,316
out of 14,075
48th
Division
Manufacturing
2,760
out of 5,486
50th
Major group
Chemicals And Allied Products
904
out of 1,900
52nd
Industry group
Drugs
703
out of 1,543
54th
Industry
Pharmaceutical Preparations
559
out of 1,173
52nd
Source: SEC filing on April 21, 2017.

Donley's colleagues

We found four more compensation records of executives who worked with Max Donley at Sucampo Pharmaceuticals in 2016.

2016

Peter Greenleaf

Sucampo Pharmaceuticals

Chief Executive Officer

2016

Peter Kiener

Sucampo Pharmaceuticals

Chief Scientific Officer

2016

Matthias Alder

Sucampo Pharmaceuticals

General Counsel

2016

Andrew Smith

Sucampo Pharmaceuticals

Chief Financial Officer

News

You may also like